Comparative LDL-C Lowering Efficacy of Non-Statin Therapies: Inclisiran is Better than Ezetimibe, PCSK9 inhibitors, and Bempedoic Acid.

Santulli, Gaetano, Urna Kansakar, Stanislovas S Jankauskas, and Fahimeh Varzideh. “Comparative LDL-C Lowering Efficacy of Non-Statin Therapies: Inclisiran Is Better Than Ezetimibe, PCSK9 Inhibitors, and Bempedoic Acid.”. Journal of Cardiovascular Pharmacology, 2025.